Atossa Genetics to Present at Two Upcoming Investor Conferences
09. Januar 2014 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jan 9, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that management will present at two upcoming investor conferences:...
Atossa Genetics Acquires Rights to Patents Covering a Novel Screening Test for Breast Cancer From the Dr. Susan Love Research Foundation
13. Juli 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jul 13, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Completes $6.6 Million Over-Subscribed Private Placement
27. Juni 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jun 27, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics Announces Licensing of Its New National Reference Laboratory for Breast Health
24. Mai 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 24, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. and HLB, LLC Announce Partnership to Manufacture Atossa's Patented, FDA-Cleared MASCT System for Breast Cancer Risk Assessment
03. Mai 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA and CHICAGO, IL--(Marketwire - May 3, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular...
Steven C. Quay, M.D., Ph.D., of Atossa Genetics Elected as a Fellow of the College of American Pathologists
14. März 2011 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Seattle Business Magazine Recognizes Steven C. Quay, M.D., Ph.D., of Atossa Genetics, Inc., as One of the Pacific Northwest's Top Leaders in Health Care
04. März 2011 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - March 4, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
01. Oktober 2010 09:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Appoints Robert L. Kelly as President
25. Mai 2010 09:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 25, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
25. Februar 2010 11:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - February 25, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...